Navigation Links
PharmaSURVEYOR's Advanced Drug Safety Service Connects to Microsoft HealthVault

Personalized drug assessment tool allows members to identify, diagnose and resolve drug side effects and interactions

SEATTLE, June 11 /PRNewswire/ -- PharmaSURVEYOR ( announced the integration of their Advanced Drug Safety service with Microsoft HealthVault at the Microsoft Connected Health Conference. PharmaSURVEYOR offers a personalized drug assessment tool designed to show users not only drug-drug interactions but the much more common and often dangerous adverse drug side effects. HealthVault users will be able to run a survey of medications stored in their HealthVault account and PharmaSURVEYOR users will be able to easily create a HealthVault account to store their medications.

"PharmaSURVEYOR is proud to join the growing ecosystem of services connected by HealthVault," said Erick Von Schweber, Executive Co-Chair of PharmaSURVEYOR. "For example, a consumer can download a family member's medications to HealthVault from their pharmacy, run an Advanced Drug Safety survey of those medications and search for any symptoms they're having in PharmaSURVEYOR. Their safety survey will reveal which of their symptoms may actually be side effects, the medications that are more likely causing these and possible substitute drugs that can reduce their risk. The Advanced Drug Safety survey can be used in collaboration with their doctor to identify and diagnose those problems and get them resolved."

PharmaSURVEYOR is the only technology that goes beyond interaction checking to help reveal and reduce combined risks - the risks that add up across the drugs in a regimen even in the absence of chemical interactions. Combined risks were responsible for the death of Heath Ledger and other celebrities, whose drugs did not interact yet combined to lethal effect. While celebrity fatalities are highly visible, adverse effects and interactions are responsible for one in ten deaths in the U.S. - amounting to 4,000 fatalities every week - and have been estimated to cost the U.S. economy over $177 billion annually.

"Drug interaction checkers only flag interaction problems, not combined risks, and they don't help to resolve any problems; PharmaSURVEYOR does!" said Mr. Von Schweber. "PharmaSURVEYOR enables the HealthVault user to perform 'what-if' analyses, like using a spreadsheet, to simulate and evaluate the safety impact of changes to their drug regimen. There's nothing else like it."

About PharmaSURVEYOR

PharmaSURVEYOR, the most advanced drug safety utility, goes far beyond drug interaction checkers, is free to consumers at and is available as an online service for integration with healthcare websites, EMR, EHR, PHR and medical applications including Drug Utilization Review, Medication Therapy Management and Medication Reconciliation. For more information, contact Linda Von Schweber at, (877) 797-8783 x102.

This release was issued through eReleases(TM). For more information, visit

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IMAGINE Software Unveils Advanced IMAGINEradiology(TM) Features
2. I-SPY trial offers key insights into locally advanced breast cancer
3. Vaccine shows therapeutic promise against advanced melanoma
4. Study shows drug combination improves outcome for advanced non-small cell lung cancer
5. Chemo Alone Is Best for Advanced Colon Cancer
6. 1 in 10 advanced colon cancer patients worry about prescription drug costs
7. One in ten advanced colon cancer patients worry about prescription drug costs
8. Advanced Life Sciences Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Restanza(TM) (cethromycin)
9. More Living Longer With Advanced Colon Cancer
10. Advanced Technologies Pump Growth Into European Cardiac Rhythm Management Market, Affirms Frost & Sullivan
11. Advanced Prostate Cancer Deadlier in Younger Men
Post Your Comments:
(Date:11/27/2015)... ... ... the No.1 Herpes-only dating community in the world, revealed that over 50% of its members ... billion people under the age of 50 – or 67% of the population - are ... of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder ...
(Date:11/27/2015)... ... 27, 2015 , ... Keeping in mind challenges faced by ... wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular activities for ... parents and bring advice from parenting experts within their reach. As a part ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
(Date:11/26/2015)... ... November 26, 2015 , ... The ... bioavailability and the need to integrate dose form selection in early phase drug ... the membership organization supporting and bringing together the UK’s emerging life sciences companies, ...
(Date:11/26/2015)... ... November 26, 2015 , ... Health-E-minds ... collaborated with Women’s Web – an online resource for Indian women looking ... and emotional well-being relationship, life balance, stress, professional development, and lifestyle. Health-E-minds ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "Radioimmunoassay Market ... User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic ... - Global Forecast to 2020" report ... ) has announced the addition of the ...
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
Breaking Medicine Technology: